Skip to content

AVANOS MEDICAL, INC.

Delisted

CIK 1606498fmd_0PBCBSCGRF1F0KYX277HE093WNManufacturing · Orthopedic, Prosthetic & Surgical Appliances & SuppliesTemplate: Standard

Coverage: Jan 01, 2012 to Mar 31, 2026, 52 periods

Latest annual · FY2025

Millions
Total revenues
701
Gross profit
354
Operating income
(62)
Net income
(73)
Free cash flow
43

Latest quarter · Q1 FY2026

Millions
Total revenues
182
Gross profit
94
Operating income
9
Net income
5
Free cash flow
(17)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2022 to FY2025
+0.8%
Revenue, 5 yearsFY2020 to FY2025
-0.4%
Net income, 5 yearsFY2020 to FY2025
n/m

AVANOS MEDICAL, INC. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2025FY2024ChangeSource
Revenue$701.2 million$687.8 million+1.9%10-K 2026-02-24 · proof
Gross profit$353.9 million$381.3 million-7.2%10-K 2026-02-24 · proof
Operating income-$61.6 million-$396.2 million10-K 2026-02-24 · proof
Net income-$72.9 million-$392.1 million10-K 2026-02-24 · proof
Cash from operating activities$74.7 million$100.7 million-25.8%10-K 2026-02-24 · proof
Free cash flow$43.1 million$82.9 million-48%10-K 2026-02-24 · proof
Total assets$1.1 billion$1.2 billion-7%10-K 2026-02-24 · proof
Total liabilities$295.5 million$325.7 million-9.3%10-K 2026-02-24 · proof
Cash and cash equivalents$89.8 million$107.7 million-16.6%10-K 2026-02-24 · proof
Total debt$100.5 million$134.7 million-25.4%10-K 2026-02-24 · proof
What was AVANOS MEDICAL, INC.'s revenue in fiscal 2025?
AVANOS MEDICAL, INC. reported revenue of $701.2 million for fiscal 2025 (the year ended Dec 31, 2025), against $687.8 million the year before (+1.9%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What was AVANOS MEDICAL, INC.'s gross profit in fiscal 2025?
AVANOS MEDICAL, INC. reported gross profit of $353.9 million for fiscal 2025 (the year ended Dec 31, 2025), against $381.3 million the year before (-7.2%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What was AVANOS MEDICAL, INC.'s operating income in fiscal 2025?
AVANOS MEDICAL, INC. reported operating income of -$61.6 million for fiscal 2025 (the year ended Dec 31, 2025), against -$396.2 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What was AVANOS MEDICAL, INC.'s net income in fiscal 2025?
AVANOS MEDICAL, INC. reported net income of -$72.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -$392.1 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What was AVANOS MEDICAL, INC.'s cash from operating activities in fiscal 2025?
AVANOS MEDICAL, INC. reported cash from operating activities of $74.7 million for fiscal 2025 (the year ended Dec 31, 2025), against $100.7 million the year before (-25.8%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What was AVANOS MEDICAL, INC.'s free cash flow in fiscal 2025?
AVANOS MEDICAL, INC. reported free cash flow of $43.1 million for fiscal 2025 (the year ended Dec 31, 2025), against $82.9 million the year before (-48%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What are AVANOS MEDICAL, INC.'s total assets?
As of Dec 31, 2025, AVANOS MEDICAL, INC. reported total assets of $1.1 billion, against $1.2 billion a year earlier (-7%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What are AVANOS MEDICAL, INC.'s total liabilities?
As of Dec 31, 2025, AVANOS MEDICAL, INC. reported total liabilities of $295.5 million, against $325.7 million a year earlier (-9.3%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What are AVANOS MEDICAL, INC.'s cash and cash equivalents?
As of Dec 31, 2025, AVANOS MEDICAL, INC. reported cash and cash equivalents of $89.8 million, against $107.7 million a year earlier (-16.6%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What is AVANOS MEDICAL, INC.'s total debt?
As of Dec 31, 2025, AVANOS MEDICAL, INC. reported total debt of $100.5 million, against $134.7 million a year earlier (-25.4%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1606498&period_type=annual&limit=5"

Information only, not investment advice.